Peak Pharmaceuticals, Inc. (OTCMKTS:PKPH – Get Free Report) traded up 29.4% during trading on Monday . The stock traded as high as $5.50 and last traded at $5.50. 400 shares changed hands during trading, a decline of 96% from the average session volume of 9,053 shares. The stock had previously closed at $4.25.
Peak Pharmaceuticals Stock Performance
The company has a 50 day simple moving average of $2.64 and a 200 day simple moving average of $2.72.
Peak Pharmaceuticals Company Profile
Peak Pharmaceuticals, Inc manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ.
Read More
- Five stocks we like better than Peak Pharmaceuticals
- Comparing and Trading High PE Ratio Stocks
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is a Low P/E Ratio and What Does it Tell Investors?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Stock Average Calculator
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Peak Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Peak Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
